No Data
No Data
Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights
8 analysts have expressed a variety of opinions on Health Catalyst (NASDAQ:HCAT) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table summarizes their
Health Catalyst Is Maintained at Buy by Canaccord Genuity
Health Catalyst Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Health Catalyst, Maintains $11 Price Target
Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite
Health Catalyst(HCAT.US) Officer Sells US$14,462 in Common Stock
$Health Catalyst(HCAT.US)$ Officer Llewelyn Linda sold 2,066 shares of common stock on May 15, 2024 at an average price of $7 for a total value of $14,462.Source: Announcement What is statement of cha
Express News | Health Catalyst Inc : Jefferies Cuts Target Price to $10 From $12
No Data